David Kaufman
Plastic Surgery · Folsom, CANPI 1841214186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.3% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.0% of the total.
Across 140 payments — averaging $48.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Integra Lifesciences Corporation$1K
- Sientra, Inc.$1K
- Mentor Worldwide LLC$642
- Merz North America, Inc.$586
- TELA Bio, Inc.$394
- plus $1K from 13 others
Across 2 payments — averaging $9500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$17K
- AbbVie$3K
What the payments were for
- Food & beverage$6,15990%
- Education$80%
- Other$65210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $1,638 |
| Integra Lifesciences Corporation | 8 | $1,167 |
| Sientra, Inc. | 21 | $1,069 |
| Mentor Worldwide LLC | 12 | $642 |
| Merz North America, Inc. | 8 | $586 |
| TELA Bio, Inc. | 4 | $394 |
| Galderma Laboratories, L.p. | 26 | $351 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $223 |
| Kerecis Limited | 2 | $162 |
| Davol Inc. | 2 | $118 |
| Innovation Technologies Inc | 2 | $111 |
| Revance Therapeutics, Inc. | 2 | $107 |
| Stryker | 1 | $75 |
| Lifenet Health | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Medline Industries LP | 1 | $23 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DuraSorb Monofilament Mesh$652
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$602
- INTEGRA$590
- NATRELLE SALINE-FILLED BREAST IMPLANTS$459
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$332
- INTEGRA DERMAL REGENERATION TEMPLATE$232
- XEOMIN$127
- PRIMATRIX$126
- NATRELLE$124
- OMNIGRAFT$107
- SURGIMEND$107
How this compares
$6,819 in reported general payments places this provider in the 75th percentile of 780 plastic surgery providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aprepitant | 12 | $864 |
| Ondansetron OdtOndansetron | 26 | $167 |
| Gabapentin | 25 | $103 |
| Cephalexin | 26 | $61 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Folsom
- Rahm NazeraliPalo Alto$1.5M
- Vipul DevBakersfield$1.1M
- Arash MomeniPalo Alto$836K
- Anne PeledSan Francisco$570K
- Salvatore PacellaSan Diego$517K
- Hani SbitanySan Francisco$510K
- John ApostolidesSan Diego$460K
- Garrett WirthNewport Beach$362K
- Michael BainNewport Beach$341K
- Joshua KormanMountain View$335K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.